NCT05211245

Brief Summary

Pain and trismus caused by Myalgia in masticatory muscles are one of the prime concerns for the patients. Various studies have been performed using US therapy for myofascial pain syndrome of head \& neck region. US is a non-invasive frequently used physical agent which increase blood flow in tissues and collagen fibers ability to grow, \& reduce muscle spasm with its thermal effect. It is difficult to imply the results of studies performed in muscles of other regions of body to the maxillofacial region because of the superficial placement of these muscles.US is being frequently used for myofascial pain, but there is an absence of a consensus regarding the frequency and mode of administration available in literature for administration of this therapy in maxillofacial region. Therefore, the present study has been designed to compare the therapeutic effect of two modes of US i.e., continuous and pulsed at 3 MHz frequency

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

August 12, 2021

Completed
6 months until next milestone

First Posted

Study publicly available on registry

January 27, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2022

Completed
Last Updated

March 14, 2023

Status Verified

March 1, 2023

Enrollment Period

1.2 years

First QC Date

August 12, 2021

Last Update Submit

March 13, 2023

Conditions

Keywords

Therapeutic ultrasound

Outcome Measures

Primary Outcomes (10)

  • To evaluate the intensity of pain in each group

    Visual Analog Scale (VAS) 0n a scale of 0-10

    Base line

  • To evaluate the intensity of pain in each group

    Visual Analog Scale (VAS) 0n a scale of 0-10

    2 weeks

  • To evaluate the intensity of pain in each group

    Visual Analog Scale (VAS) 0n a scale of 0-10

    4weeks

  • To evaluate the intensity of pain in each group

    Visual Analog Scale (VAS) 0n a scale of 0-10

    6 weeks

  • To evaluate the intensity of pain in each group

    Visual Analog Scale (VAS) 0n a scale of 0-10

    3 months

  • To assess pressure pain sensitivity of muscles in the two groups.

    Algometer

    Base line

  • To assess pressure pain sensitivity of muscles in the two groups.

    Algometer

    2 weeks

  • To assess pressure pain sensitivity of muscles in the two groups.

    Algometer

    4 weeks

  • To assess pressure pain sensitivity of muscles in the two groups.

    Algometer

    6 weeks

  • To assess pressure pain sensitivity of muscles in the two groups.

    Algometer

    3 months

Secondary Outcomes (6)

  • To evaluate the maximal mouth opening and functional movements

    Base line

  • To evaluate the maximal mouth opening and functional movements

    2 weeks

  • To evaluate the maximal mouth opening and functional movements

    Base line ,2 weeks,4 weeks ,6 weeks, 3 months post treatment

  • To evaluate patient psychological status

    Base line ,2 weeks,4 weeks ,6 weeks, 3 months post treatment

  • To evaluate quality of life

    Base line ,2 weeks,4 weeks ,6 weeks, 3 months post treatment

  • +1 more secondary outcomes

Study Arms (2)

Pulse mode

EXPERIMENTAL

Pulsed mode of US results in nonthermal effect i.e., micro massage like which lead to segmental analgesia due to decreased central \& peripheral sensitization. The non-thermal effect of US can be explain by frequency resonance theory which states that the proteins in these structures absorbs mechanical energy thus altering the structure \& function, finally resulting in stimulation of phagocytosis, increase number of free radicals, increase cell membrane permeability, cellular proliferation \&acceleration of fibrinolysis

Device: therapeutic ultrasound

Continous mode

ACTIVE COMPARATOR

Thermal effect which is a result of continuous mode of US therapy causes transient increase in the flexibility of collagenous structures including ligaments, tendons \& joint capsules, thus leading to decrease in the pain \& muscle spasm, stiffness of the joint \& temporary increase in the blood flow.

Device: therapeutic ultrasound

Interventions

Therapeutic ultrasound ranges from 750,000 to 3,300,000 Hz (0.75 to 3.3 MHz). Depending upon the output parameters it may produce effects like increase tissue extensibility, reduction of calcium deposits, reduction of pain \& muscle spasm by altering nerve conduction velocity \& changes in cell membrane permeability along with increased rate of tissue repair \& wound healing.There are two main types of ultrasound therapy: thermal and mechanical. Thermal effect which is a result of continuous mode of US therapy causes transient increase in the flexibility of collagenous structures including ligaments, tendons \& joint capsules, thus leading to decrease in the pain \& muscle spasm, stiffness of the joint \& temporary increase in the blood flow. Pulsed mode of US results in nonthermal effect i.e., micro massage like which lead to segmental analgesia due to decreased central \& peripheral sensitization.

Continous modePulse mode

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with myalgia within orofacial muscle as per DC/TMD (Ia and Ib)
  • Patient's consent for participation in this study.

You may not qualify if:

  • Patients with epilepsy/seizures
  • Patients with radiographic changes suggestive of pathological conditions of temporomandibular joint (TMJ).
  • Patients with undiagnosed orofacial pain
  • Any sort of skin lesion at the site where electrode is to be placed.
  • Therapeutic ultrasound must not be applied over areas of impaired circulation, ischemic areas, or areas having sensory deficit.
  • Sites of active infection
  • Patients with metal prosthesis
  • Patients with Becks depression score \>25 will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PGIDS

Rohtak, Haryana, 124001, India

Location

Related Publications (1)

  • Saini B, Gupta A, Singh H, Bisla S, Nagarajan S, Kumia K. Effectiveness of continuous and pulse mode of ultrasound therapy in temporomandibular disorders associated myalgia-a randomized controlled study. J Oral Facial Pain Headache. 2025 Mar;39(1):81-92. doi: 10.22514/jofph.2025.007. Epub 2025 Mar 12.

MeSH Terms

Conditions

Myalgia

Interventions

Ultrasonic Therapy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesMusculoskeletal PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

DiathermyHyperthermia, InducedTherapeutics

Study Officials

  • Dr. Ambika Gupta, MDS

    oral medicine & radiology,PGIDS

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2021

First Posted

January 27, 2022

Study Start

August 1, 2021

Primary Completion

October 15, 2022

Study Completion

October 15, 2022

Last Updated

March 14, 2023

Record last verified: 2023-03

Locations